FDA could authorize Novavax COVID-19 vaccine

Name: FDA could authorize Novavax COVID-19 vaccine
Uploaded: 2022-06-09T21:40:39Z
Duration: 3 min
Description: Novavax is protein-based vaccine, developed with the same technology used to make vaccines for Hepatitis B and shingles.

Novavax is protein-based vaccine, developed with the same technology used to make vaccines for Hepatitis B and shingles.

Posted June 9, 2022 5:40pm EDT